W. B. Frijlink

TREATMENT OF PAGET'S DISEASE WITH (3-AMINO-1-HYDROXYPROPYLIDENE)-1, 1-BISPHOSPHONATE (A.P.D.)

W. B. Frijlink, OlavL.M. Bijvoet, J. te Velde et al. · The Lancet · 1979 · 259 citations

Medicine, Pharmacotherapy, Chemotherapy +3

Apd in paget's disease of bone role of the mononuclear phagocyte system?

O. L. M. Bijvoet, W. B. Frijlink, Kon‐Siong G. Jie et al. · Arthritis & Rheumatism · 1980 · 133 citations

Medicine, Immunology, Pathology +9

Efficacy of amino-hydroxypropylidene bisphosphonate in hypercalcemia: Observations on regulation of serum calcium

F.J.M. van Breukelen, O. L. M. Bijvoet, W. B. Frijlink et al. · Calcified Tissue International · 1982 · 68 citations

Medicine, Pharmacotherapy, Bone Metabolism +12

Relation Between Signs and Symptoms in Paget's Disease of Bone

H.I.J. Harinck, O. L. M. Bijvoet, C.J.L.R. Vellenga et al. · QJM · 1986 · 65 citations

Medicine, Nuclear Medicine, Pathology +17

Regulation of calcium absorption by 1,25,dihydroxy-vitamin D—Studies of the effects of a bisphosphonate treatment

S. Adámi, W. B. Frijlink, O. L. M. Bijvoet et al. · Calcified Tissue International · 1982 · 51 citations

Medicine, Endocrinology, Nutrition +16